Description
Trade name:
Broncho-Vaxom adult
Compound:
Each capsule contains:
Standardized lyophilisate OM-85, containing 7 mg of bacterial lysates:
Haemophilus influenzae, Streptococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Moraxella catarrhalis.
Properties:
An immunostimulating drug of bacterial origin. Causes an immune response in the mucous membrane of the digestive tract. The effect is especially evident in the Peyer’s patches (PP) of the small intestine. Antigen-presenting cells (APC) in the PP are activated by the drug and subsequently stimulate cells responsible for specific immunity.
When using the drug, an increase in the number of circulating B-lymphocytes is observed. After stimulation of B-lymphocytes, an increase in the production of polyclonal antibodies is observed, especially serum IgG and IgA secreted by the mucous membrane of the respiratory tract and saliva. These antibodies are the first line of defense against a number of infectious agents (viruses and bacteria).
The drug has a powerful stimulating effect on most types of leukocytes, as evidenced by an increase in the number of myeloid and lymphoid cells, as well as a selective increase in the expression of receptors on their surface.
Taken together, these data provide evidence that the drug triggers biological responses that enhance the body’s immune defenses against infection.
Indications:
Adults and children 12 years of age and older:
– prevention of recurrent respiratory tract infections and exacerbations of chronic bronchitis;
– treatment of acute respiratory tract infections (as part of complex therapy).
Method of administration and dosage:
For the treatment of acute and exacerbation of chronic respiratory tract infections: 1 capsule of Broncho-Vaxom for adults daily in the morning on an empty stomach until symptoms disappear, but not less than 10 days. If antibiotic therapy is necessary, Broncho-Vaxom for adults should be taken in combination with an antibiotic from the beginning of treatment.
The duration of treatment should be determined by the doctor, based on the patient’s health condition.
For the prevention of exacerbations and maintenance therapy: 1 capsule of Broncho-Vaxom for adults daily in the morning on an empty stomach. The course includes 3 cycles, each of which consists of daily intake of 1 capsule for 10 days, the interval between cycles is 20 days.
If the capsule is difficult to swallow, open it and mix the contents with a drink (water, fruit juice, milk).
Contraindications:
-pregnancy;
– lactation period;
– hypersensitivity to the components of the drug.
Precautions:
The components of the drug may cause hypersensitivity reactions. In case of persistent gastrointestinal disorders, skin reactions, respiratory disorders or other symptoms of drug intolerance, treatment should be discontinued, since these symptoms are a manifestation of an allergic reaction.
Side effects:
From the immune system: uncommon – hypersensitivity reactions (erythematous rash, generalized rash, erythema, edema, eyelid edema, facial edema, peripheral edema).
From the nervous system: often – headache.
From the respiratory system, chest organs and mediastinum: often – cough.
From the gastrointestinal tract: often – diarrhea, abdominal pain; uncommon – nausea, vomiting. From the skin and subcutaneous tissues: often – rash.
Storage method:
Store at temperatures not exceeding 25 degrees.
